The CyP inhibitor CRV431 inhibited liver HBV DNA and hepatitis B surface antigen in vivo [50] and CyPA was overexpressed in HCC promoting cell cycle [51]. The gene discussed is PPIA; the disease is hepatocellular carcinoma.